216762
Seminar
The Drug Discovery Process in the Pharmaceutical Industry - From target to hit identification
Roman Hillig, Holger Steuber
Information for students
Die Teile (I im SS und II im WS) können in beliebiger Reihenfolge besucht werden, sie sind nicht aufbauend.
Additional information / Pre-requisites
Seminars 216761 and 216762 can be attended in arbitrary sequence, they do not build-up on each other.
Comments
Content:
1. Target Identification and Hit Finding
2. X-ray Crystallography in DD
3. Molecular Modeling
4. Fragment-Based Drug Design
5. New Modalities, New target Classes
6. Target Class: Ras GTPase superfamily
7. Target Class: Epigenetic Targets
8. Nuclear Magnetic Resonance
Dr. R. Hillig: roman.hillig@nuvisan.com
Dr. H. Steuber: holger.steuber@ nuvisan.com close
1. Target Identification and Hit Finding
2. X-ray Crystallography in DD
3. Molecular Modeling
4. Fragment-Based Drug Design
5. New Modalities, New target Classes
6. Target Class: Ras GTPase superfamily
7. Target Class: Epigenetic Targets
8. Nuclear Magnetic Resonance
Dr. R. Hillig: roman.hillig@nuvisan.com
Dr. H. Steuber: holger.steuber@ nuvisan.com close
More search results for 'Vom Aufschieben verabschieden. Ein ...'